Mounjaro and Ozempic users face fines for driving with side effects

Thousands of UK women taking weight loss jabs may not realise they could be breaking the law behind the wheel. Motoring experts are warning that side effects like dizziness and fatigue could land you with a fine of up to £1,000. Here is everything you need to know before you drive.

If you are taking Mounjaro or Ozempic, there is something important you may not have considered. Driving while impaired by medication side effects is illegal in the UK — and weight loss jabs are no exception. (LadBible UK, 21 May 2026)

Motoring experts have issued a warning that Mounjaro and Ozempic users face fines of up to £1,000 if side effects such as dizziness or fatigue affect their ability to drive safely. The warning applies whether your prescription is private or NHS. (LadBible UK, 21 May 2026)

This matters because hundreds of thousands of UK women are now taking these injections. Many are managing demanding daily lives — including the school run, commuting, and caring for others. Driving is not optional for most of them.

Why dizziness and fatigue are so common on these jabs

Mounjaro contains tirzepatide, a drug that acts on two hormones — GLP-1 and GIP — to reduce appetite and slow digestion. Ozempic contains semaglutide, which works on GLP-1 alone. Both are injected once a week. (MHRA, 2024)

Slowing digestion means food sits in your stomach longer. This can cause nausea, low energy, and blood sugar dips — especially in the first few weeks on a new dose. These are the exact conditions that can affect your reactions behind the wheel. (Electronic Medicines Compendium, tirzepatide SmPC, 2024)

Dizziness is listed as a known side effect for both semaglutide and tirzepatide. Fatigue — feeling unusually tired — is also commonly reported by users, particularly during dose escalation, when the dose is stepped up every four weeks. (Electronic Medicines Compendium, semaglutide SmPC, 2024)

Most women experience the worst side effects in the first one to two weeks after each dose increase. After that, symptoms often ease. But that window of vulnerability is real, and it matters when you are operating a vehicle. (MHRA patient information, 2024)

What does the law actually say?

Under the Road Traffic Act 1988, it is an offence to drive while unfit through drugs — including prescribed medication. The law does not distinguish between illegal drugs and legal ones. What matters is whether your ability to drive safely is impaired. (Road Traffic Act 1988, legislation.gov.uk)

The DVLA also has its own rules. Drivers have a legal duty to tell the DVLA about any medical condition or medication that could affect their driving. Failing to do so can result in a fine of up to £1,000. (DVLA, gov.uk, 2024)

Here is the problem that motoring experts have flagged specifically for Mounjaro and Ozempic users. If your prescription is private — not through your GP — it may not appear on your NHS medical records. That creates a gap. If you are involved in an accident and impairment is suspected, investigators may find no record of your treatment at all. (LadBible UK, 21 May 2026)

This does not protect you legally. It may actually make things more complicated. The responsibility to declare the medication sits with you, not your private clinic.

Do you need to tell the DVLA you are taking Mounjaro or Ozempic?

This is where many women get confused, so let us be clear. Mounjaro and Ozempic are not on the DVLA’s list of specified controlled drugs that automatically require declaration. However, the DVLA’s guidance is broader than that list. (DVLA, gov.uk, 2024)

You must tell the DVLA if you have a condition or are taking medication that affects your fitness to drive. If your side effects — dizziness, fatigue, nausea — are significant enough to impair your reactions, you have a legal and moral obligation to act on that. (DVLA, gov.uk, 2024)

The safest approach is to speak to the doctor or prescriber who gave you the jabs. Ask them directly whether your current dose and side effect profile require DVLA notification. Get that conversation in writing if you can.

Practical steps to stay safe and legal

You do not need to stop driving altogether. Most Mounjaro and Ozempic users drive safely throughout their treatment. But there are sensible precautions worth taking, particularly in the early weeks. (MHRA patient information, 2024)

Track your side effects honestly. Keep a simple note on your phone. Write down when you feel dizzy, unusually tired, or nauseous — and whether you were driving or had planned to drive that day.

Be cautious after a dose increase. The 24 to 48 hours after stepping up your dose are when side effects tend to peak. Consider avoiding long drives or motorway driving during this window.

Do not drive if you feel unwell. This sounds obvious. But many women push through fatigue out of habit or necessity. If you feel genuinely impaired, the same rule applies as with a bad cold or a sleepless night — give yourself permission to stop.

Tell your prescriber everything. Whether you use a private clinic or a telehealth service, they need to know if your side effects are affecting daily life. This is precisely the kind of information that should be in your notes. (MHRA, 2024)

The bigger issue: private prescriptions and the information gap

The motoring warning has highlighted a wider concern about Mounjaro and Ozempic users face fines risk being compounded by the way private prescribing works in the UK. (LadBible UK, 21 May 2026)

When you see your NHS GP, your full medication list is visible to anyone treating you in an emergency. When your weight loss jab comes from a private provider, that information often exists in a separate system. Paramedics, A&E teams, and traffic police may have no idea what you are taking. (NHS England, Medicines Information, 2024)

This is not unique to weight loss jabs. But the sheer number of women now using private GLP-1 prescriptions — semaglutide and tirzepatide combined — makes it a pressing practical issue. Industry estimates suggest over 300,000 people in the UK are now on privately prescribed GLP-1 treatments. (Association of British HealthTech Industries, 2024)

The simplest solution is to tell your NHS GP that you are taking a privately prescribed GLP-1. Ask them to add it to your GP record. Most GPs will do this. It protects you medically and legally.

What if you have already been driving without thinking about this?

Do not panic. The vast majority of people taking these medications drive without incident. The law is not designed to catch people who are managing their treatment responsibly. It exists to protect everyone on the road — including you. (Road Traffic Act 1988, legislation.gov.uk)

Going forward, the key is awareness. Now that you know Mounjaro and Ozempic users face fines for driving while impaired, you can take the simple steps above to make sure you are never in that position.

If you are unsure about your specific situation, your prescriber — whether NHS or private — is the right first call. The DVLA also has a medical enquiries line if you want a direct answer about your duty to notify. (DVLA, gov.uk, 2024)

Weight loss treatment should make your life better, not more complicated. A little awareness here means you can get on with the drive — safely and legally.

This article is for information purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.

Get the UK peptide medicine briefing in your inbox.

Free weekly. No spam. Unsubscribe any time.

Looking for a UK weight loss clinic?

We’ve reviewed the main UK providers so you don’t have to.

More from The Peptide Brief